Physician profile
Seth Abel
NPI 1235510009
$2,013.75
in general payments reported to CMS, 2019-2025
19 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $342 · 2022: $298 · 2023: $419 · 2024: $658 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,374.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $609.90 | 2021-2025 | Qelbree, Qelbree |
| Pfizer INC. | $254.70 | 2021-2025 | |
| Ironshore Pharmaceuticals INC. | $235.37 | 2021-2024 | Jornay Pm |
| Corium, LLC | $161.40 | 2021-2025 | Azstarys |
| Sanofi-Aventis U.S. LLC | $105.21 | 2024-2025 | |
| Tris Pharma INC | $92.07 | 2021-2023 | Dyanavel Xr |
| Alk-Abello, INC | $89.60 | 2023-2025 | Odactra, Ragwitek, Grastek |
| Sanofi Pasteur INC. | $68.44 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.31 | 2021-2022 | |
| Verrica Pharmaceuticals INC. | $52.03 | 2024-2025 | Ycanth |
| Kaleo, INC. | $47.97 | 2021 | |
| Seqirus USA INC | $41.46 | 2023-2025 | Flucelvax Quadrivalent, Flucelvax |
| Collegium Pharmaceutical, INC. | $41.30 | 2025 | Jornay Pm |
| Alexion Pharmaceuticals, INC. | $37.92 | 2023 | Strensiq |
| Merck Sharp & Dohme LLC | $35.09 | 2021-2023 | Vaxneuvance, Rotateq, Gardasil 9 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $24.05 | 2023 | Ruconest |
| Glaxosmithkline, LLC. | $23.34 | 2023 | Bexsero |
| Neurelis, INC. | $19.06 | 2022 | |
| Neos Therapeutics, Lp | $13.53 | 2024 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Abel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.